A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin-Reference-Cited by-同舟云学术

A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin

Published:2022-06-24 Issue:9 Volume:15 Page:2159-2171
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Couroux Peter¹,Brkovic Alexandre²,Vittitow Jason L.³,Israel Robert J.³,Pamidi Chinna¹,Patel Jignesh¹,Barakat Maxime²^ORCID

Affiliation:

1. Cliantha Research Mississauga Ontario Canada

2. Bausch Health Laval Quebec Canada

3. Bausch Health Bridgewater New Jersey USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13350

Reference27 articles.

1. Virus discovery in all three major lineages of terrestrial arthropods highlights the diversity of single-stranded DNA viruses associated with invertebrates

2. World Health Organization.Joint statement by ILO FAO IFAD WHO October 13 2020. Impact of COVID‐19 on people’s livelihoods their health and our food systems. Accessed February 1 2022.https://www.who.int/news/item/13‐10‐2020‐impact‐of‐covid‐19‐on‐people's‐livelihoods‐their‐health‐and‐our‐food‐systems

3. Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

4. Reducing mortality from 2019-nCoV: host-directed therapies should be an option

5. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Clinical Pharmacokinetics of Inhaled Antiviral;Medicina;2023-03-23

2. Ribavirin aerosol in hospitalized adults with respiratory distress and COVID ‐19: An open‐label trial;Clinical and Translational Science;2022-11-03